Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities (Tables)

v3.24.3
Accrued Expenses and Other Current Liabilities (Tables)
 9 Months Ended
Sep. 30, 2024
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): 
  As of
  September 30, 2024 December 31, 2023
Research and development $ 775  $ 352 
Compensation and benefits 2,192  580 
General and administrative 386  830 
Private placement investment transaction costs 1,734  — 
Commercial operations 1,155  1,873 
Royalty payment 241  — 
Lease liability, current 550  537 
Total accrued expenses and other current liabilities $ 7,033  $ 4,172